The symposium will feature enlightening presentations from key opinion leaders on immunotherapy innovations and advancements in immune cell therapy manufacturing, including NK-cell based and T-cell based therapies. Engage in interactive discussions and network with academia and industry cell therapy experts during our evening mingle event.
Co-Chairs: Anna Pacetto, PhD, and Kalle Malmberg, PhD, Oslo University Hospital, Norway
12:00-12:30 Light lunch, soda and coffee served outside the auditorium
12:30-14:10 Session 1:
Non-viral strategies for CAR T engineering Steven Feldman, PhD, Laboratory for Cell and Gene Medicine Stanford GMP Facility, US
Adoptive cell therapy for solid tumor up TIL now Özcan Met, PhD, National Center for Cancer Immune Therapy, Herlev University Hospital, Denmark
Early phase manufacturing hurdles for an autologous T-Cell Therapy Andrea Salmén, MSc, NEOGAP Therapeutics, Sweden
14:10-14:30 Coffee and snacks
14:30-16:10 Session 2:
A smoother path for tomorrow’s regenerative medicine Jim Lund, PhD, CCRM Nordic
Development of allogeneic TCR-NK cell therapies for solid cancers Anders Holm, PhD, Zelluna Immunotherapy, Norway
Applying flexible and scalable solutions to overcome cell therapy manufacturing challenges Evan Zynda, PhD, Thermo Fisher Scientific, US
16:10-17:00 Light food and mingling outside the auditorium
